Development of a prokaryotic model for studying anthracycline-membrane interactions. 1994

S M Burrow, and C E Rolph, and J J Waring, and D A Phoenix
Department of Applied Biology, University of Central Lancashire.

UI MeSH Term Description Entries
D007544 Isopropyl Thiogalactoside A non-metabolizable galactose analog that induces expression of the LAC OPERON. IPTG,Isopropyl 1-Thio-beta-D-galactopyranoside,1-Thio-beta-D-galactopyranoside, Isopropyl,Isopropyl 1 Thio beta D galactopyranoside,Thiogalactoside, Isopropyl
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial
D017855 Transferases (Other Substituted Phosphate Groups) A class of enzymes that transfers substituted phosphate groups. EC 2.7.8. Phosphotransferases (Other Substituted Phosphate Groups)
D018432 Drug Resistance, Multiple Simultaneous resistance to several structurally and functionally distinct drugs. Drug Resistance, Extensively,Extensively Drug Resistance,Extensively-Drug Resistance,Multidrug Resistance,Multi-Drug Resistance,Extensively Drug Resistances,Extensively-Drug Resistances,Multiple Drug Resistance,Resistance, Extensively Drug,Resistance, Extensively-Drug,Resistance, Multiple Drug

Related Publications

S M Burrow, and C E Rolph, and J J Waring, and D A Phoenix
September 1984, Biochimica et biophysica acta,
S M Burrow, and C E Rolph, and J J Waring, and D A Phoenix
August 1995, Biophysical journal,
S M Burrow, and C E Rolph, and J J Waring, and D A Phoenix
January 2013, Stem cell research & therapy,
S M Burrow, and C E Rolph, and J J Waring, and D A Phoenix
August 2014, Biochimica et biophysica acta,
S M Burrow, and C E Rolph, and J J Waring, and D A Phoenix
January 1983, Alcoholism, clinical and experimental research,
S M Burrow, and C E Rolph, and J J Waring, and D A Phoenix
January 1982, Scanning electron microscopy,
S M Burrow, and C E Rolph, and J J Waring, and D A Phoenix
January 1994, Recent progress in hormone research,
S M Burrow, and C E Rolph, and J J Waring, and D A Phoenix
May 1989, Applied and environmental microbiology,
S M Burrow, and C E Rolph, and J J Waring, and D A Phoenix
March 1999, Proceedings of the National Academy of Sciences of the United States of America,
S M Burrow, and C E Rolph, and J J Waring, and D A Phoenix
October 2022, Pharmaceutics,
Copied contents to your clipboard!